Aytu Biopharma, Inc. (AYTU)
2.14
+0.02
(+0.94%)
USD |
NASDAQ |
Sep 21, 16:00
2.14
0.00 (0.00%)
After-Hours: 20:00
Aytu Biopharma Shareholders Equity (Quarterly) : 35.14M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 35.14M |
| December 31, 2025 | 14.20M |
| September 30, 2025 | 23.17M |
| June 30, 2025 | 18.97M |
| March 31, 2025 | 34.90M |
| December 31, 2024 | 30.76M |
| September 30, 2024 | 29.83M |
| June 30, 2024 | 27.72M |
| March 31, 2024 | 30.78M |
| December 31, 2023 | 32.85M |
| September 30, 2023 | 32.17M |
| June 30, 2023 | 39.36M |
| March 31, 2023 | 40.91M |
| December 31, 2022 | 45.82M |
| September 30, 2022 | 48.35M |
| June 30, 2022 | 44.31M |
| March 31, 2022 | 61.14M |
| December 31, 2021 | 105.54M |
| September 30, 2021 | 111.50M |
| June 30, 2021 | 137.57M |
| March 31, 2021 | 143.15M |
| December 31, 2020 | 112.69M |
| September 30, 2020 | 91.06M |
| June 30, 2020 | 95.02M |
| March 31, 2020 | 85.70M |
| Date | Value |
|---|---|
| December 31, 2019 | 17.09M |
| September 30, 2019 | 2.324M |
| June 30, 2019 | 7.088M |
| March 31, 2019 | 16.04M |
| December 31, 2018 | 19.90M |
| September 30, 2018 | 10.13M |
| June 30, 2018 | 13.42M |
| March 31, 2018 | 12.75M |
| December 31, 2017 | 3.031M |
| September 30, 2017 | 6.353M |
| June 30, 2017 | 4.000M |
| March 31, 2017 | 8.521M |
| December 31, 2016 | 10.45M |
| September 30, 2016 | 7.187M |
| June 30, 2016 | 10.09M |
| March 31, 2016 | 17.57M |
| December 31, 2015 | 15.26M |
| September 30, 2015 | 13.41M |
| June 30, 2015 | |
| March 31, 2015 | 0.5513M |
| February 28, 2015 | -0.0529M |
| November 30, 2014 | -0.0441M |
| August 31, 2014 | -0.045M |
| May 31, 2014 | -0.036M |
| February 28, 2014 | -0.1478M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 84.97B |
| Eli Lilly & Co. | 33.88B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 111.69M |
| Total Liabilities (Quarterly) | 76.55M |
| Debt to Equity Ratio | 0.6527 |
| Current Ratio | 1.123 |
| Net Debt Paydown Yield | -3.96% |